Anthony C. Sulpizio

N-((1 S)-1-{[4-((2 S)-2-{[(2,4-Dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a Novel and Potent Transient Receptor Potential Vanilloid 4 Channel Agonist Induces Urinary Bladder Contraction and Hyperactivity: Part I

Kevin S. Thorneloe, Anthony C. Sulpizio, Zuojun Lin et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 400 citations

Systemic Activation of the Transient Receptor Potential Vanilloid Subtype 4 Channel Causes Endothelial Failure and Circulatory Collapse: Part 2

Robert N. Willette, Weike Bao, Sandhya S. Nerurkar et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 291 citations

Differential vasoconstrictor activity of human urotensin‐II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey

Stephen A. Douglas, Anthony C. Sulpizio, Valerie Piercy et al. · British Journal of Pharmacology · 2000 · 227 citations · Full text

Hypertension, Cardiac Anatomy, Mammalian Physiology +22

Identification of a Selective Nonpeptide Antagonist of the Anaphylatoxin C3a Receptor That Demonstrates Antiinflammatory Activity in Animal Models

Robert S. Ames, Dennis Lee, James J. Foley et al. · The Journal of Immunology · 2001 · 200 citations · Full text

Immunology, Competitive Antagonist, Immunologic Mechanism +18

Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage.

Xiaoyang Wang, Tongpeng Yue, Frank C. Barone et al. · Proceedings of the National Academy of Sciences · 1995 · 195 citations · Full text